{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:24:30Z","timestamp":1778621070062,"version":"3.51.4"},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-158","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:11:57Z","timestamp":1418256717000},"page":"56-61","source":"Crossref","is-referenced-by-count":8,"title":["Periprocedural Anticoagulation of Patients Undergoing Pericardiocentesis for Cardiac Tamponade Complicating Catheter Ablation of Atrial Fibrillation"],"prefix":"10.1536","volume":"56","author":[{"given":"Tao","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-hui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-bo","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-hua","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-nan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-sheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-zeng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Calkins H, Kuck KH, Cappato R, <i>et al<\/i>. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012; 33: 171-257. (Review)","DOI":"10.1007\/s10840-012-9672-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hsu LF, Ja\u00efs P, Hocini M, <i>et al<\/i>. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol 2005; 28: S106-9.","DOI":"10.1111\/j.1540-8159.2005.00062.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hsu LF, Scav\u00e9e C, Ja\u00efs P, Hocini M, Ha\u00efssaguerre M. Transcardiac pericardiocentesis: an emergency life-saving technique for cardiac tamponade. J Cardiovasc Electrophysiol 2013; 14: 1001-3.","DOI":"10.1046\/j.1540-8167.2003.03153.x"},{"key":"4","unstructured":"4. Themistoclakis S, China P. Whether and when oral anticoagulation therapy should be discontinued after successful ablation of atrial fibrillation. And what about the risk of bleeding? The reasons for not discontinuing oral anticoagulant therapy. G Ital Cardiol (Roma) 2013; 14: 272-6. (Italian)"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bertaglia E, Zoppo F, Tondo C, <i>et al<\/i>. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 2007; 4: 1265-71.","DOI":"10.1016\/j.hrthm.2007.06.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ha\u00efssaguerre M, Hocini M, Sanders P, <i>et al<\/i>. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: 1138-47.","DOI":"10.1111\/j.1540-8167.2005.00308.x"},{"key":"7","unstructured":"7. Sang C, Jiang C, Dong J, <i>et al<\/i>. A new method to evaluate linear block at the left atrial roof: is it reliable without pacing? J Cardiovasc Electrophysiol 2010; 21: 741-6."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bunch TJ, Asirvatham SJ, Friedman PA, <i>et al<\/i>. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 2005; 16: 1172-9.","DOI":"10.1111\/j.1540-8167.2005.50135.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hoyt H, Bhonsale A, Chilukuri K, <i>et al<\/i>. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm 2011; 8: 1869-74.","DOI":"10.1016\/j.hrthm.2011.07.025"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lip GY, Andreotti F, Fauchier L, <i>et al<\/i>. Bleeding risk assessment andmanagement in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 2011; 13: 723-46.","DOI":"10.1093\/europace\/eur126"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Scherr D, Sharma K, Dalal D, <i>et al<\/i>. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 1357-63.","DOI":"10.1111\/j.1540-8167.2009.01540.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. O\u2019Neill MD, Ja\u00efs P, Derval N, Hocini M, Haissaguerre M. Two techniques to avoid surgery for cardiac tamponade occurring during catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2008; 19: 323-5.","DOI":"10.1111\/j.1540-8167.2007.00973.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chilukuri K, Henrikson CA, Dalal D, <i>et al<\/i>. Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2009; 25: 175-81.","DOI":"10.1007\/s10840-009-9364-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Latchamsetty R, Gautam S, Bhakta D, <i>et al<\/i>. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm 2011; 8: 805-8.","DOI":"10.1016\/j.hrthm.2011.01.020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shah N, Sarode R. Warfarin reversal: schism between clinical practice and published guidelines. Transfusion 2013; 53: 476-9.","DOI":"10.1111\/trf.12104"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hirsh J, Dalen J, Anderson DR, <i>et al<\/i>. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21S. (Review)","DOI":"10.1378\/chest.119.1_suppl.8S"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hanslik T, Prinseau J. The use of vitamin K in patients on anticoagulation therapy: a practical guide. Am J Cardiovasc Drugs 2004; 4: 43-5. (Review)","DOI":"10.2165\/00129784-200404010-00005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Willms L, Vercaigne LM. Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety. Semin Dial 2008; 21: 71-7. (Review)","DOI":"10.1111\/j.1525-139X.2007.00381.x"},{"key":"19","unstructured":"19. Warkentin TE, Crowther MA. Reversing anticoagulants both old and new. Can J Anaesth 2002; 49: S11-25. (Review)"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mannucci C, Douketis JD. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians. Intern Emerg Med 2006; 1: 96-104. (Review)","DOI":"10.1007\/BF02936533"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Imamura K,Yoshida A, Takei A, <i>et al<\/i>. Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay. J Interv Card Electrophysiol 2013; 37: 223-31.","DOI":"10.1007\/s10840-013-9801-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chang DN, Dager WE, Chin AI. Removal of dabigatran by hemodialysis. Am J Kidney Dis 2013; 61: 487-9.","DOI":"10.1053\/j.ajkd.2012.08.047"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kaireviciute D, Lip GY, Balakrishnan B, <i>et al<\/i>. Intracardiac expression of markers of endothelial damage\/ dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation. J Thromb Haemost 2011; 9: 2345-52.","DOI":"10.1111\/j.1538-7836.2011.04523.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sparks PB, Jayaprakash S, Vohra JK, <i>et al<\/i>. Left atrial \u201cstunning\u201d following radiofrequency catheter ablation of chronic atrial flutter. J Am Coll Cardiol 1998; 32: 468-75.","DOI":"10.1016\/S0735-1097(98)00253-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pisters R, Lip GY. Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do.and what should we do? Can J Cardiol 2013; 29: 139-41.","DOI":"10.1016\/j.cjca.2012.05.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hamm CW, Bassand JP, Agewall S, <i>et al<\/i>. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent STsegment elevation of the European Society of Cardilogy (ESC) . Eur Heart J 2011; 32: 2999-3054.","DOI":"10.1093\/eurheartj\/ehr236"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wazni OM, Beheiry S, Fahmy T, <i>et al<\/i>. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116: 2531-4.","DOI":"10.1161\/CIRCULATIONAHA.107.727784"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Vazquez SR, Johnson SA, Rondina MT. Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thrombosis Research 2010; 126: e69-77. (Review)","DOI":"10.1016\/j.thromres.2009.11.031"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shah A, van den Brink A, de Mol B. Raised international normalized ratio: an early warning for a late cardiac tamponade? Ann Thorac Surg 2006; 82: 1090-1.","DOI":"10.1016\/j.athoracsur.2006.01.035"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Saad EB, d\u2019Avila A, Costa IP, <i>et al<\/i>. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS<sub>2<\/sub> score \u2264 3 : a long-term outcome study. Circulation Arrhythm Electrophysiol 2011; 4: 615-21.","DOI":"10.1161\/CIRCEP.111.963231"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Okumura Y. Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy? J Cardiovasc Electrophysiol 2009; 20: 994-6.","DOI":"10.1111\/j.1540-8167.2009.01512.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hayashi T, Kumagai K, Naito S, <i>et al<\/i>. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin. Circulation 2013; 77: 338-44.","DOI":"10.1253\/circj.CJ-12-0743"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T09:49:01Z","timestamp":1566121741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/1\/56_14-158\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-158","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}